Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell Activity

Zhiming Cheng1, Emily J Thompson1, Lorena Mendive-Tapia1

  • 1Centre for Inflammation Research The University of Edinburgh Edinburgh UK.

Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)
|March 22, 2024
PubMed

Insights

Researchers developed new near-infrared probes to detect active granzyme A (GzmA), a key molecule in anti-tumor immunity. These probes enable real-time imaging of immune cell responses to cancer, advancing cancer research.

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • Cytotoxic lymphocytes (CTLs) and natural killer (NK) cells are crucial for anti-tumor immunity.
  • These cells release granzyme A (GzmA) upon encountering cancer cells.
  • Existing tools lack the resolution to detect active GzmA at physiological levels.

Purpose of the Study:

  • To design and synthesize novel near-infrared fluorogenic substrates for human and mouse GzmA.
  • To develop activity-based probes for detecting active GzmA with high spatiotemporal resolution.
  • To visualize adaptive immune cell responses during cancer cell recognition in real time.

Main Methods:

  • Rational design of near-infrared fluorogenic substrates.
  • Synthesis of probes targeting GzmA.
  • Validation using tissue lysates from wild-type and GzmA knock-out mice.
  • In vivo imaging of immune cell-cancer interactions.

Main Results:

  • Developed highly efficient and selective near-infrared fluorogenic probes for GzmA.
  • Demonstrated probe selectivity over other granzymes.
  • Successfully imaged adaptive immune cell responses to antigen-driven cancer cell recognition in real time.

Conclusions:

  • The novel GzmA probes provide a powerful tool for studying anti-tumor immunity.
  • These probes facilitate real-time visualization of immune cell activity against cancer.
  • This technology has potential applications in cancer immunotherapy research and diagnostics.